Contact Dirk

Speaking Engagements

  

Validate Your Preclinical Hypothesis by Dissecting Solid Tumor Microenvironment, Predictive Biomarker, Safety & Clinical Efficacy Analysis through Next Gen Models & Bioinformatics The last 12 months witnessed the surge of exciting combination immuno-oncology data, but stakes remain high with clinical translation.

25-27 January 2022
  

With 2023 on track to see further growth in the immuno-oncology field, the availability of tools that offers drug developers & researchers advantages that weren’t available to them even a few years ago is increasing rapidly.

24-26 January 2023
  

Join us at the 5th Treg Summit, where we will be discussing the latest advancements in IL-2 and CAR-Treg therapies, and how advanced engineering and product design can enhance their tissue specificity, durability, stability, and safety, thus accelerating their clinical translation.

With investment in the Treg field at an all-time high, the

30 May-01 June 2023